RR

Ramamohan Rao Davuluri

Active Director Whole-Time Director DIN 00107737
DIN 00107737 First appointment Jan 1984 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 3 historical roles
Total affiliations 5 Since Jan 1984
Shareholding value •••• Premium profile

About Ramamohan Rao Davuluri

Data last updated:

Ramamohan Rao Davuluri is a Whole-Time Director at Neuland Laboratories Ltd (since 1984) and Director at Pattancheru Enviro-Tech Limited (since 1996). The companies operate in Pharma and Environment. The 2 current companies with reported revenue have a combined latest revenue of ₹1,517 Cr; the largest is Neuland Laboratories Ltd at ₹1,497 Cr (FY 2025). Earlier, Ramamohan Rao Davuluri was a Director at Asvi Therapeutics Private Limited (from 2020) and Director at Neuland Health Sciences Private Limited (from 2012) and 1 more.

DIN 00107737
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 07 Jan 1984
Oldest Company Age 42 yrs
Largest company Neuland Laboratories Ltd · ₹1,497 Cr (FY 2025)
Combined revenue ₹1,517 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Neuland Laboratories Ltd L85195TG1984PLC004393
Whole-Time Director07 Jan 19841984₹1,497 Cr (FY 2025)Active
Pattancheru Enviro-Tech Limited U29219TG1989PLC009683
Director06 Aug 19961989₹19.79 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Asvi Therapeutics Private Limited U24230TG2020PTC146436
Director01 Dec 20202020Strike Off
Director16 Apr 20121993₹580 Cr (FY 2017)Amalgamated
Director23 Apr 20122012₹61.52 Cr (FY 2017)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Asvi Therapeutics Private Limited
Pattancheru Enviro-Tech Limited
Neuland Health Sciences Private Limited
Neuland Pharma Research Private Limited
Premium access

Shareholding and investment profile for Ramamohan Rao Davuluri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramamohan Rao Davuluri

Ramamohan Rao Davuluri currently holds 2 directorships: Neuland Laboratories Ltd (Whole-Time Director, since 07 Jan 1984, revenue ₹1,497 Cr (FY 2025)); Pattancheru Enviro-Tech Limited (Director, since 06 Aug 1996, revenue ₹19.79 Cr (FY 2025)).

Ramamohan Rao Davuluri was first appointed on 07 Jan 1984 as Whole-Time Director at Neuland Laboratories Ltd. The most recent appointment on record is 01 Dec 2020 at Asvi Therapeutics Private Limited.

The 2 current companies of Ramamohan Rao Davuluri that report revenue have a combined latest revenue of ₹1,517 Cr: Neuland Laboratories Ltd ₹1,497 Cr (FY 2025); Pattancheru Enviro-Tech Limited ₹19.79 Cr (FY 2025).

Ramamohan Rao Davuluri held 3 earlier board appointments: Asvi Therapeutics Private Limited (Director, from 01 Dec 2020); Neuland Health Sciences Private Limited (Director, from 16 Apr 2012); Neuland Pharma Research Private Limited (Director, from 23 Apr 2012).

The current boards of Ramamohan Rao Davuluri's companies include Abhijit Ajay Majumdar (Neuland Laboratories Ltd), Homi Rustam Khusrokhan (Neuland Laboratories Ltd), Mauricio Futran (Neuland Laboratories Ltd), Pallavi Joshi Bakhru (Neuland Laboratories Ltd), Prasad Raghava Menon (Neuland Laboratories Ltd), Ravi Shankar Gopinath (Neuland Laboratories Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available